Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD

European Respiratory Journal - Tập 24 Số 3 - Trang 391-396 - 2004
Brigitte W.M. Willemse1
1University Hospital Groningen, Dept of Pathology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.

Tóm tắt

Smoking induces chronic obstructive pulmonary disease (COPD) and is associated with airway inflammation and airway hyperresponsiveness (AHR). It has not been studied in COPD whether direct (methacholine) and indirect (adenosine-5'-monophosphate (AMP)) stimuli are associated with airway inflammation and neither whether smoking cessation improves these features.The current authors cross-sectionally investigated the relationship of AHR to methacholine and AMP with lung function and inflammatory cells in the sputum of 33 smokers with COPD. In addition, changes in these parameters were prospectively assessed in 14 smokers who successfully quit smoking for 1 yr.The presence of AHR to both methacholine and AMP was associated with lower lung function, but not with sputum inflammation. AHR to methacholine and AMP improved significantly after a 1-yr smoking cessation, yet this was unrelated to changes in sputum cell counts. The numbers of neutrophils and epithelial cells significantly increased with smoking cessation.Both direct and indirect airway hyperresponsiveness are associated with lower lung function, but not with sputum inflammation in chronic obstructive pulmonary disease. Interestingly, 1-yr smoking cessation improved both direct and indirect airway hyperresponsiveness, yet without a significant association with changes in lung function or sputum inflammation. Thus, other factors are likely to induce these improvements,e.g.a reduction in stimulation of irritant receptors, airway wall changes or mucus hypersecretion.

Từ khóa


Tài liệu tham khảo

10.1164/ajrccm.158.supplement_2.13tac170

1992, Am Rev Respir Dis, 145, 301, 10.1164/ajrccm/145.2_Pt_1.301

1985, Am Rev Respir Dis, 132, 25

1995, Am J Respir Crit Care Med, 151, 635

10.1016/S0954-6111(96)90126-2

1995, Am J Respir Crit Care Med, 152, 267, 10.1164/ajrccm.152.1.7599834

10.1136/thx.39.12.912

10.1164/ajrccm/145.6.1251

10.1001/jama.1994.03520190043033

1977, Br Med J, 1, 1645, 10.1136/bmj.1.6077.1645

1993, Eur Respir J, 16, 53

10.1164/ajrccm/137.1.57

10.1164/ajrccm/147.3.553

10.1378/chest.124.2.449

2001, Am J Respir Crit Care Med, 163, 1546, 10.1164/ajrccm.163.7.2010145

10.1164/ajrccm.164.7.2102135

1986, Am Rev Respir Dis, 133, 120, 10.1164/arrd.1986.133.1.120

10.1046/j.1365-2222.2000.00819.x

10.1183/09031936.95.08081398

1993, Eur Respir J Suppl, 16, 5

10.1111/j.1365-2222.1977.tb01448.x

2000, Eur Respir J, 15, 109, 10.1183/09031936.00.15110900

1993, Am Rev Respir Dis, 147, 1126, 10.1164/ajrccm/147.5.1126

10.1016/S0140-6736(86)90837-8

10.1016/S0002-9343(99)00056-X

10.1046/j.1365-2222.1998.00382.x

1983, Am Rev Respir Dis, 127, 474, 10.1164/arrd.1983.127.4.474

2001, Thorax, 56, II7

1991, Int Arch Allergy Appl Immunol, 94, 303, 10.1159/000235392

10.1063/1.360142

10.1034/j.1399-3003.2000.016003514.x

1994, Am J Respir Crit Care Med, 149, 1311, 10.1164/ajrccm.149.5.8173772

10.1136/thx.43.8.599

1995, Am J Respir Crit Care Med, 152, 1926, 10.1164/ajrccm.152.6.8520757

10.1378/chest.123.3.778

Thông tin
Thông tin xuất bản

European Respiratory Journal

Tập 24 Số 3

391-396

Thông tin tác giả